In this context, hyperglycemia results from defects in both insulin secretion and insulin function, and most patients with T2DM are treated with oral medications.[6] However, patients presenting with the clinical and pathophysiological characteristics of both T1DM and T2DM have previously been reported. The gene discussed is INS; the disease is Hyperglycemia.